Avicanna Inc. (AVCNF)
OTCMKTS · Delayed Price · Currency is USD
0.1650
-0.0020 (-1.20%)
Dec 24, 2025, 4:00 PM EST
Avicanna Market Cap
Avicanna has a market cap or net worth of $19.85 million as of December 24, 2025. Its market cap has decreased by -19.54% in one year.
Market Cap
19.85M
Enterprise Value
25.79M
Revenue
18.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.17
Market Cap Chart
Since July 18, 2019, Avicanna's market cap has decreased from 104.82M to 19.85M, a decrease of -81.06%. That is a compound annual growth rate of -22.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 19.79M | -15.27% |
| Dec 31, 2024 | 23.36M | -2.78% |
| Dec 29, 2023 | 24.03M | 5.84% |
| Dec 30, 2022 | 22.71M | -19.71% |
| Dec 31, 2021 | 28.28M | -26.61% |
| Dec 31, 2020 | 38.54M | -11.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 724.00M |
| Elite Pharmaceuticals | 520.52M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 376.54M |
| CytoDyn | 359.24M |
| Nika Pharmaceuticals | 291.10M |
| Silence Therapeutics | 290.02M |